Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer

NCT06204094 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

RADIATION: node-sparing short-course radiotherapy
DRUG: Sintilimab
DRUG: Capecitabine
DRUG: Oxaliplatin
PROCEDURE: TME surgery
PROCEDURE: watch and wait

Sponsor

Jinhua Central Hospital